Uptake of influenza vaccination in rheumatology patients: Reply [2]

Rheumatology

Volumn 44, Issue 1, 2005, Pages 131-

  Thomas, L M ^a   Wood, A ^a   Shenton, S ^a   Ledingham, Jo M ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; CONTROLLED STUDY; GENERAL PRACTITIONER; GOVERNMENT; GROUPS BY AGE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VACCINATION; INFORMATION DISSEMINATION; INTERVIEW; LETTER; MAJOR CLINICAL STUDY; MASS MEDIUM; MEDICAL INFORMATION; OUTPATIENT CARE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; STATISTICAL SIGNIFICANCE; WINTER;

ADULT; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RHEUMATIC DISEASES; VACCINATION;

EID: 12344250887     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keh452     Document Type: Letter

References (3)

1. Saravana S. Uptake of influenza vaccination in rheumatology patients. Rheumatology 2004;43:1055.
2. Shenton S, Wood A, McCrae F et al. Age divide in the uptake of pneumox and influenza vaccination amongst rheumatology patients taking disease modifying anti-rheumatic drugs. Rheumatology 2004;(Suppl 2):ii161.
3. Department of Health. Update on immunization issues. August 2002. London: Department of Health, 2002.